AGF Investments LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 47.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,707 shares of the healthcare conglomerate’s stock after buying an additional 866 shares during the period. UnitedHealth Group makes up about 0.1% of AGF Investments LLC’s holdings, making the stock its 26th biggest holding. AGF Investments LLC’s holdings in UnitedHealth Group were worth $1,058,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently added to or reduced their stakes in the company. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the 2nd quarter worth approximately $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $28,000. Activest Wealth Management bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $29,000. Tompkins Financial Corp bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $32,000. Finally, Annapolis Financial Services LLC lifted its holdings in shares of UnitedHealth Group by 57.9% in the 3rd quarter. Annapolis Financial Services LLC now owns 90 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 33 shares during the last quarter. 86.10% of the stock is owned by institutional investors and hedge funds.
Shares of NYSE:UNH opened at $468.69 on Friday. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.59. The business has a fifty day moving average of $470.11 and a two-hundred day moving average of $436.18. The stock has a market cap of $441.44 billion, a P/E ratio of 29.08, a PEG ratio of 1.49 and a beta of 0.86. UnitedHealth Group Incorporated has a 52-week low of $320.35 and a 52-week high of $509.23.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th were issued a dividend of $1.45 per share. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date of this dividend was Friday, December 3rd. UnitedHealth Group’s dividend payout ratio is presently 35.98%.
In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total value of $33,654,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Tuesday, November 23rd. The shares were sold at an average price of $444.70, for a total value of $1,111,750.00. The disclosure for this sale can be found here. Corporate insiders own 0.55% of the company’s stock.
Several brokerages have commented on UNH. The Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a report on Tuesday, December 14th. They issued a “buy” rating and a $535.00 price objective for the company. SVB Leerink initiated coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They set an “outperform” rating and a $480.00 price objective on the stock. Evercore ISI upped their target price on shares of UnitedHealth Group from $360.00 to $480.00 and gave the company an “outperform” rating in a research note on Friday, October 15th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $421.00 to $477.00 and gave the stock a “buy” rating in a research note on Tuesday, November 16th. Finally, UBS Group raised their target price on shares of UnitedHealth Group from $435.00 to $452.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 1st. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a hold rating, twenty-two have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $500.54.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Featured Story: What is channel trading?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.